dc.contributor.author | MacDonald, TM | en_US |
dc.contributor.author | Mackenzie, IS | en_US |
dc.contributor.author | Rogers, A | en_US |
dc.contributor.author | Poulter, NR | en_US |
dc.contributor.author | Williams, B | en_US |
dc.contributor.author | Brown, MJ | en_US |
dc.contributor.author | Webb, DJ | en_US |
dc.contributor.author | Ford, I | en_US |
dc.contributor.author | Rorie, D | en_US |
dc.contributor.author | Grieve, K | en_US |
dc.contributor.author | Pigazzani, F | en_US |
dc.contributor.author | Rothwell, PM | en_US |
dc.contributor.author | Young, R | en_US |
dc.contributor.author | McConnachie, A | en_US |
dc.contributor.author | Lang, CC | en_US |
dc.date.accessioned | 2023-10-17T10:48:08Z | |
dc.date.available | 2023-10-17T10:48:08Z | |
dc.date.issued | 2023-01 | en_US |
dc.identifier.issn | 0263-6352 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/91349 | |
dc.format.extent | e65 - ? | en_US |
dc.publisher | Wolters Kluwer | en_US |
dc.relation.ispartof | Journal of Hypertension | en_US |
dc.subject | Clinical Trials and Supportive Activities | en_US |
dc.subject | Heart Disease | en_US |
dc.subject | Hypertension | en_US |
dc.subject | Aging | en_US |
dc.subject | Comparative Effectiveness Research | en_US |
dc.subject | Clinical Research | en_US |
dc.subject | Cardiovascular | en_US |
dc.subject | Patient Safety | en_US |
dc.subject | 6 Evaluation of treatments and therapeutic interventions | en_US |
dc.subject | 6.1 Pharmaceuticals | en_US |
dc.subject | Cardiovascular | en_US |
dc.subject | 3 Good Health and Well Being | en_US |
dc.title | S-28-1: CARDIOVASCULAR OUTCOMES IN ADULTS WITH HYPERTENSION WITH EVENING VERSUS MORNING DOSING OF USUAL ANTIHYPERTENSIVES IN THE UK. THE TIME STUDY | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1097/01.hjh.0000913348.28687.10 | en_US |
pubs.issue | Suppl 1 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 41 | en_US |